| [1] |
中华医学会骨科学分会.骨质疏松骨折诊疗指南[J].中华骨科杂志, 2008, 28(10): 875-878.
|
| [2] |
邱贵兴，裴福兴，胡侦明,等.中国骨质疏松性骨折诊疗指南（骨质疏松性骨折诊断及治疗原则）[J].中华骨与关节外科杂志, 2015 (5): 371-374.
|
| [3] |
Bliuc D, Nguyen ND, Alarkawi D, et al. Accelerated bone loss and increased post-fracture mortality in elderly women and men [J]. Osteoporo Int, 2015, 26(4): 1331-1339.
|
| [4] |
孙爱军，林守清，余卫,等.经皮用雌二醇预防中国妇女绝经早期骨丢失[J].中华医学杂志(英文版), 2002, 115(12): 1790-1795.
|
| [5] |
Schmder HM, Peterson KK, Erlandsen M. Occurrence and incidence of the second hip fracture [J]. Clin Orthop, 1993, 289: 166-169.
|
| [6] |
Goldhahn J, Little D, Mitchell P, et al. Evidence for anti-osteoporosis therapy in acute fracture situations--recommendations of a multidisciplinary workshop of the International Society for Fracture Repair[J]. Bone, 2010, 46(2): 267-271.
|
| [7] |
中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南[J].中华骨质疏松和骨矿盐疾病杂志, 2011, 4(1): 2-17.
|
| [8] |
吴青，朱汉民.骨质疏松基础防治措施对老年人25羟基维生素D水平和下肢肌力及平衡功能的影响[J].中华老年医学杂志, 2014, 33(10): 1135-1138.
|
| [9] |
张秀珍，宣淼，李颖,等.一项为期18个月、多中心应用重组人甲状旁腺激素(1-34)与依降钙素治疗绝经后骨质疏松症的随机、对照临床试验研究[J].中华内分泌代谢杂志, 2015 (2): 120-126.
|
| [10] |
李国新，袁忠治，温健,等.口服及静脉应用双磷酸盐治疗绝经后的骨质疏松临床研究[J].中国骨质疏松杂志, 2013, 19(9): 988-990.
|
| [11] |
陈琳，游利，陈瑾瑜,等.应用阿仑膦酸钠治疗绝经后骨质疏松失效改用雷洛昔芬的疗效观察[J].中华骨质疏松和骨矿盐疾病杂志, 2015 (2): 132-137.
|
| [12] |
Khosla S. Increasing options for the treament of osteoporosis [J]. N Engl J Med, 2009, 361(8): 818-820.
|
| [13] |
Cosman F, Eriksen EF, Recknor C, et al. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis [J]. J Bone Miner Res, 2011, 26(3): 503-511.
|
| [14] |
Eriksen EF, Keaveny TM, Gallagher ER, et al. Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis [J]. Bone, 2014, 67: 246-256.
|
| [15] |
Sone T, Masako I, Fukunaga M, et al. The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk [J]. Bone, 2014 (64): 75-81.
|
| [16] |
余倩，吴晶.骨质疏松症患者药物依从性及影响因素分析[J].中国骨质疏松杂志, 2014, 20(7): 789-794.
|
| [17] |
Balasubramanian A, Tosi LL, Lane JM, et al. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009 [J]. J Bone Joint Surg Am, 2014, 96(7): e52.
|
| [18] |
Klop C, Gibson-Smith D, Elders PJ, et al. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010 [J]. Osteoporos Int, 2015, 26(7): 1919-1928.
|